AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Feb 4, 2015
29828_dirs_2015-02-04_27e4b6d2-4186-499b-adce-83306bcd02d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-02-02
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-02 | Common Stock | M | 10000 | $19.085 | Acquired | 123694 | Direct |
| 2015-02-02 | Common Stock | S | 3630 | $105.2028 | Disposed | 120064 | Direct |
| 2015-02-02 | Common Stock | S | 6270 | $106.0692 | Disposed | 113794 | Direct |
| 2015-02-02 | Common Stock | S | 100 | $107.03 | Disposed | 113694 | Direct |
| 2015-02-02 | Common Stock | S | 1500 | $105.2666 | Disposed | 112194 | Direct |
| 2015-02-02 | Common Stock | S | 500 | $106.352 | Disposed | 111694 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-02 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 10000 | Disposed | 2021-01-20 | Common Stock (10000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $104.72 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $105.7424 to $106.5615. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $104.94 to $105.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $106.07 to $106.94. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.